FLT4 and atherosclerosis: Collecting lymphatic vessel function is disturbed at a very early stage before atherosclerosis onset and linked to LDLR absence, and this defective transport can be prevented by enhancing VEGF-C/VEGFR-3 specific binding in a cholesterol-independent manner.